Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdose
- 10 May 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Intensive Care Medicine
- Vol. 32 (7), 1060-1065
- https://doi.org/10.1007/s00134-006-0183-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Citalopram overdose: Late presentation of torsades de pointes (TdP) with cardiac arrestJournal of Medical Toxicology, 2008
- Pharmacokinetic–pharmacodynamic modelling of QT interval prolongation following citalopram overdosesBritish Journal of Clinical Pharmacology, 2005
- The Population Pharmacokinetics of Citalopram After Deliberate Self-Poisoning: A Bayesian ApproachJournal of Pharmacokinetics and Pharmacodynamics, 2005
- A randomized clinical trial of activated charcoal for the routine management of oral drug overdoseQJM: An International Journal of Medicine, 2005
- Sample Size, Power Calculations, and Their Implications for the Cost of Thorough Studies of Drug Induced QT Interval ProlongationPacing and Clinical Electrophysiology, 2004
- Dynamic Beat-to-Beat Modeling of the QT-RR Interval Relationship: Analysis of QT Prolongation during Alterations of Autonomic State versus Human Ethera-go-go-Related Gene InhibitionJournal of Pharmacology and Experimental Therapeutics, 2004
- Bupropion Overdose: QTc Prolongation and its Clinical SignificanceAnnals of Pharmacotherapy, 2003
- Citalopram and demethylcitalopram in human milk; distribution, excretion and effects in breast fed infantsBritish Journal of Clinical Pharmacology, 2000
- Fatal overdose with citalopramThe Lancet, 1996
- The Kinetics of Citalopram: Single and Multiple Dose Studies in ManActa Pharmacologica et Toxicologica, 1981